Evidence map›Paper›PMID 28487845›Full record

ArticleFrontiers in cellular and infection microbiology2017

Eutirucallin: A Lectin with Antitumor and Antimicrobial Properties.

Julio G Palharini, Aline C Richter, Mariana F Silva, Flavia B Ferreira, Carlos P Pirovani, Karinne S C Naves, Vivian A Goulart, Tiago W P Mineo, Marcelo J B Silva, Fernanda M Santiago

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. The Search for Drugs Derived from Natural Products forCurrent topics in medicinal chemistry · 2024
    Pooled it
  2. Article
  3. A Review of the Leishmanicidal Properties of Lectins.Current protein & peptide science · 2024
    Review
  4. Article
  5. Article
  6. Inhibitory effects ofMolecular and clinical oncology · 2019
    Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Julio G PalhariniLaboratory of Immunoparasitology "Dr. Mario Endsfeldz Camargo", Institute of Biomedical Sciences, Federal University of UberlândiaUberlândia, Brazil.
Aline C RichterLaboratory of Immunoparasitology "Dr. Mario Endsfeldz Camargo", Institute of Biomedical Sciences, Federal University of UberlândiaUberlândia, Brazil.
Mariana F SilvaLaboratory of Immunoparasitology "Dr. Mario Endsfeldz Camargo", Institute of Biomedical Sciences, Federal University of UberlândiaUberlândia, Brazil.
Flavia B FerreiraLaboratory of Immunoparasitology "Dr. Mario Endsfeldz Camargo", Institute of Biomedical Sciences, Federal University of UberlândiaUberlândia, Brazil.
Carlos P PirovaniBiological Sciences Department, State University of Santa CruzIlhéus, Brazil.
Karinne S C NavesLaboratory of Clinical Bacteriology, Institute of Biomedical Sciences, Federal University of UberlândiaUberlândia, Brazil.
Vivian A GoulartLaboratory of Nanobiotechnology, Institute of Genetics and Biochemistry, Federal University of UberlândiaUberlândia, Brazil.
Tiago W P MineoLaboratory of Immunoparasitology "Dr. Mario Endsfeldz Camargo", Institute of Biomedical Sciences, Federal University of UberlândiaUberlândia, Brazil.
Marcelo J B SilvaLaboratory of Tumor Biomarkers and Osteoimmunology, Institute of Biomedical Sciences, Federal University of UberlândiaUberlândia, Brazil.
Fernanda M SantiagoLaboratory of Immunoparasitology "Dr. Mario Endsfeldz Camargo", Institute of Biomedical Sciences, Federal University of UberlândiaUberlândia, Brazil.
Universidade Federal de Uberlândia · BRUniversidade Estadual de Santa Cruz · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Eutirucallin is a lectin isolated from the latex of

Indexed as

AnimalsAnti-Infective AgentsAntineoplastic AgentsAntiparasitic AgentsBrazilCarcinoma, Ehrlich TumorCell Line, TumorCell ProliferationCell SurvivalDrug StabilityEscherichia coliEuphorbiaFibroblastsHeLa CellsHemagglutinationHumansAnti-Infective AgentsAntineoplastic AgentsAntiparasitic Agentseutirucallin protein, Euphorbia tirucalliLectinsPlant ExtractsPlant LectinsEhrlich ascites carcinomaEscherichia coliEuphorbia tirucalliEutirucallin lectinToxoplasma gondii

Identifiers

PMID28487845
PMCPMC5403948
OpenAlexW2609010682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.